Live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. Common probiotic genera include Lactobacillus, Bifidobacterium, and Saccharomyces (yeast). Probiotics must survive gastric acid, colonize (temporarily) the gut, and produce beneficial metabolites.
Probiotics exert effects through multiple mechanisms: (1) competitive exclusion of pathogens for nutrients and binding sites, (2) production of antimicrobial substances (bacteriocins, lactic acid, hydrogen peroxide), (3) enhancement of gut barrier function (increased tight junction proteins, mucin production), (4) modulation of immune responses (dendritic cell tolerization, Treg induction), (5) production of beneficial metabolites (SCFAs, vitamins, neurotransmitter precursors), (6) bile acid metabolism. Strain-specific effects are critical—not all probiotics have same functions.
Probiotics often fail because they're added to an environment that won't support them. In cPNI, probiotics are never first-line intervention—must first address the milieu (pH, oxygen levels, substrate availability, inflammation). The colonocytes must be consuming oxygen (creating anaerobic environment), pH must be appropriate, and sufficient prebiotic fiber needed. Probiotics are strain-specific; must match strain to desired effect. Rotating strains prevents adaptation.
- Must be live, in adequate dose (typically 109-1011 CFU), and confer health benefit
- Strain-specific effects: not all Lactobacillus strains have same functions
- Most probiotics transiently colonize; do not permanently establish
- Lactobacillus and Bifidobacterium most common bacterial genera
- Saccharomyces boulardii is probiotic yeast
- Probiotics fail without appropriate substrate (prebiotics) and environment
- Some strains induce Tregs and reduce inflammation (e.g., L. reuteri)
- Psychobiotics: probiotics affecting brain function via gut-brain axis
- Requires anaerobic environment in colon for colonization
- SCFA production by probiotics requires fermentable fiber
- gut microbiome — Probiotics temporarily supplement existing microbiome
- prebiotics — Essential substrates for probiotic function and survival
- SCFAs — Produced by probiotic fermentation of prebiotics
- gut barrier — Probiotics enhance tight junction integrity and mucus production
- gut dysbiosis — Probiotics used to restore balance, but environment must be corrected first
- Lactobacillus — Major probiotic genus producing lactic acid and bacteriocins
- Bifidobacterium — Major probiotic genus dominating infant gut, producing acetate
- immune system — Probiotics modulate immune responses via dendritic cell interactions
- Treg cells — Certain probiotic strains induce Tregs promoting immune tolerance
- inflammation — Anti-inflammatory effects through immune modulation and barrier protection
- pH — Probiotics require appropriate gut pH to colonize and function
- oxygen — Most probiotics require anaerobic environment; colonocytes must consume O2
- antibiotics — Probiotics can partially mitigate antibiotic-associated dysbiosis
- IBS — Certain strains reduce IBS symptoms, but strain-specific
- depression — Psychobiotics (e.g., L. rhamnosus) may improve mood via gut-brain axis
- gut-brain axis — Probiotics influence brain function via metabolites, vagus nerve, immune modulation
- fecal microbiota transplantation — More effective than probiotics for restoring diverse microbiome
- bacteriocins — Antimicrobial peptides produced by probiotics inhibiting pathogens
- Module 2
- Module 3
- Module 6